Newsletter Nine
By Mick (BinaryG) on 07-Jul-10 23:39. Comments
(0)
Pancreatitis Supporters Newsletter Nine
November/December 1995
As promised in earlier Newsletters we now have copies of the booklets produced by Duphar/Mr Bruce Faulkner-Dunkley and written by Professor John Neoptolemos.
Newsletter Eight
By Mick (BinaryG) on 07-Jul-10 23:37. Comments
(0)
Pancreatitis Supporters Newsletter 8
We now have our own Franking Machine!!
Thank you Duphar and especially Mr Bruce Faulkner-Dunkley for your most generous donation of 500 towards the fund for the Franking Machine.
REMINDER:&n
Showing 1 - 2 of 8 Articles
Archives
Write a comment
- Required fields are marked with *.
Jessica
Posts: 21
Posts: 21
Reply #20 on : Tue April 24, 2012, 05:31:32
Sally
Posts: 21
Posts: 21
Reply #19 on : Tue April 24, 2012, 05:21:19
Eunice
Posts: 21
Posts: 21
Reply #18 on : Tue April 24, 2012, 04:24:27
Annisa
Posts: 21
Posts: 21
Reply #17 on : Tue April 24, 2012, 03:59:11
Latest News
Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive ...
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ...
AXIOS(TM) Stent and Delivery System Study Demonstrates Successful Treatment of ...
Chamomile has a life-saving secret
Dear Pharmacist: Chamomile offers a life-saving secret
Novartis drug pasireotide LAR shows superior efficacy compared to SandostatinR ...
Body at Cox was of former patient
Isis Pharmaceuticals' CEO Discusses Clinical Development Plans for ...
Blitz on foreign patients halves $30m health bill
Anti-NGF painkillers back on track?
Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with ...
REPLIGEN CORPORATION : Repligen Reports First Quarter 2012 ...
6 Biotech Stocks With Huge Potential In June
Warning about Diabetes Treatment Victoza
The Benefit of Low Fat Pet Food in Dogs with GI Disease
Repligen Says FDA May Seek More Data on Imaging Drug
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma
Amsterdam Molecular Therapeutics Reports Full Year Results 2011
Repligen says FDA may seek more data on pancreatic imaging drug
Program draws attention to the dangers of strokes
Boston Scientific Endoscopy Presents Promising Clinical Data During Digestive ...
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ...
AXIOS(TM) Stent and Delivery System Study Demonstrates Successful Treatment of ...
Chamomile has a life-saving secret
Dear Pharmacist: Chamomile offers a life-saving secret
Novartis drug pasireotide LAR shows superior efficacy compared to SandostatinR ...
Body at Cox was of former patient
Isis Pharmaceuticals' CEO Discusses Clinical Development Plans for ...
Blitz on foreign patients halves $30m health bill
Anti-NGF painkillers back on track?
Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with ...
REPLIGEN CORPORATION : Repligen Reports First Quarter 2012 ...
6 Biotech Stocks With Huge Potential In June
Warning about Diabetes Treatment Victoza
The Benefit of Low Fat Pet Food in Dogs with GI Disease
Repligen Says FDA May Seek More Data on Imaging Drug
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma
Amsterdam Molecular Therapeutics Reports Full Year Results 2011
Repligen says FDA may seek more data on pancreatic imaging drug
Program draws attention to the dangers of strokes









Posts: 21
Reply #21 on : Tue April 24, 2012, 08:08:58